Brief: CorMedix Q4 EPS USD -0.26
12/03/2024 11:38
Mar 12 (Reuters) - CorMedix Q4 basic EPS USD -0.26. * Q4 net income USD -14.8 million * Q4 EPS USD -0.26 * Q4 operating expenses USD 15.7 million
Recent news on CorMedix
See all newsBrief: Cormedix Announces FDA Acceptance For Priority Review Of Supplemental NDA For Rezzayo
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
CorMedix Inc. reports results for the quarter ended June 30 - Earnings Summary